Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-24

Clinical Trial Update: Intravitreal Ranibizumab to Treat Macular Edema After Panretinal Photocoagulation (Phase II) [Phase 2]

View source ↗

Summary

Phase 2 trial investigating intravitreal ranibizumab for macular edema following panretinal photocoagulation in proliferative diabetic retinopathy; study termin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ranibizumab (ranibizumab)

Snippet

Sponsor: Jumper, J. Michael, M.D. | Conditions: Proliferative Diabetic Retinopathy, Macular Edema | Phase 2 | Status: TERMINATED | Results posted: 2015-04-24